FYR
Missoula, Montana, United States · Artificial Intelligence, Biotechnology, Health Care
FYR Bio (FYR Diagnostics Inc) is revolutionizing the ability to dynamically observe disease and treatment response to produce better biomarkers, trials, drugs and outcomes. FYR's EV-Omics™ (EVO) platform leverages its proprietary technology, SPARCs™, to enrich for extracellular vesicles from diseased cells and enable assessment of cellular proteins and nucleic acids with a peripheral blood sample.
Key facts
- Headquarters
- Missoula, Montana, United States
- Employees
- 19
- Industries
- Artificial Intelligence, Biotechnology, Health Care
- Status
- Private
- Website
- fyr.bio
- Company page
Recent activity at FYR
FYR funding history
| Date | Round | Amount |
|---|---|---|
| Sep 2025 | Funding Round | $8.0M |
Leadership
- Barbara K. Zehentner, Chief Operating Officer
- Sarjubhai Patel, President
- Chris Booth, Chief Executive Officer
- Brett Sagan, Executive Officer
- LLC Sydecar, Director
Verified email and direct lines for FYR’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
FYR in the news
- FYR Bio Appoints Barbara K. Zehentner, MBA, PhD, HCLD (ABB), as Chief Operating Officer - BioSpace (Feb 11, 2026)
- Transfyr Launches Physical AI Platform for Science with $25M Seed Funding - Business Wire (Aug 26, 2026)
- COST re-elects chairman and welcomes FYR back into committee - CORDIS (Jun 11, 2001)
Companies similar to FYR
- Transcripta Bio · Artificial Intelligence, Biotechnology, Health Care, Therapeutics
- Paratus Sciences Corporation · Artificial Intelligence, Biotechnology, Health Care, Therapeutics
- Nephrolytics · Artificial Intelligence, Biotechnology, Health Care, Venture Capital Fund
- Pepticom · Artificial Intelligence, Biotechnology, Health Care, Therapeutics
- Shift Bioscience · Artificial Intelligence, Biotechnology, Health Care, Therapeutics
About FYR: questions and answers
What does FYR do?
FYR Bio (FYR Diagnostics Inc) is revolutionizing the ability to dynamically observe disease and treatment response to produce better biomarkers, trials, drugs and outcomes. FYR's EV-Omics™ (EVO) platform leverages its proprietary technology, SPARCs™, to enrich for extracellular vesicles from diseased cells and enable assessment of cellular proteins and nucleic acids with a peripheral blood sample.
Where is FYR headquartered?
FYR is headquartered in Missoula, Montana, United States.
How many employees does FYR have?
FYR has about 19 employees.
Has FYR raised funding?
Yes. Fundz has recorded 1 funding event for FYR. The most recent, Funding Round of $8.0M, was in Sep 2025.
Who leads FYR?
Sarjubhai Patel is a President at FYR.
What is the latest news on FYR?
On Feb 10, 2026, FYR Bio Appoints Barbara K. Zehentner as Chief Operating Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy